Author(s): Côté M; Ramos Salas X; Carrière K; Alberga AS;

Incretin-based therapies, including glucagon-like peptide-1 receptor agonists (GLP-1RAs), are approved for the treatment of type 2 diabetes, obesity, and related conditions, and have demonstrated significant benefits for individuals with these conditions. However, in recent years, public interest and demand for GLP-1RAs-often driven by media, social media ...

Article GUID: 41986775

Author(s): Kwok C; Sacco S; Lister NB; Alberga AS; Baur LA; Booij L; Carrière K; Garnett SP; Jebeile H;

Background: Pediatric obesity is associated with co-occurring psychosocial conditions, which may be impacted by obesity treatment. Past systematic reviews have shown positive effects for specific psychosocial outcomes following behavioral interventions. This review aimed to extend these findings ...

Article GUID: 41736559

Author(s): Sacco S; Booij L; Kwok C; Carrière K; Hall K; Baluyot TC; Forouhar V; Côté M; Pietrasik M; Jebeile H; Ball GDC; Johnston BC; Alberga AS;

Background: Many children and adolescents with overweight or obesity experience negative psychosocial health consequences. Systematic reviews show that behavioral interventions can help improve specific psychosocial outcomes. This scoping review aims to identify and map the different types of psy ...

Article GUID: 41601261

Author(s): Côté M; Carrière K; Alberga AS;

No abstract available

Article GUID: 39239749

Author(s): Carrière K; Siemers N; Thapar S; Knäuper B;

Background: Over fifty percent of individuals with overweight and obesity are emotional eaters. Emotional eating can be theorized as a conditioned response to eat for reasons that are not associated with physiological hunger. We conducted this proof-of-concept study to gather evidence that a mobile app that delivers a common non-meditative mindfulness exe ...

Article GUID: 39114459